Best Agrolife Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY26 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 14 Jun 2026 | Fertilizers & Agrochemicals | Market Cap: ₹743 Cr

FY26 was challenging with a 31% YoY revenue decline to ₹1,257 crore; FY27 expected to improve. FY26 was challenging with reduced revenue and profits; FY27 expected to improve but no specific guidance provided.

From Best Agrolife Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹18.2

Market Cap

₹743 Cr

P/E Ratio

25.1

How does Best Agrolife Ltd rank in Fertilizers & Agrochemicals?

Compare Best Agrolife Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

Best Agrolife Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹156 Cr, net profit ₹-37 Cr.

Full financials →

📊 Revenue & Sales Performance

→FY26 was challenging with a 31% YoY revenue decline to ₹1,257 crore; FY27 expected to improve.
→Price increases implemented in April and May 2026 expected to support profitability and top-line growth from Q1 FY27 onward.
→Deferred sales of ₹50-70 crore from March expected to reflect in Q1 FY27, leading to better turnover and profitability.
→Strategic focus on expanding B2B segment with new off-patent technical molecules in production, opening new revenue streams.
→Increased contribution from differentiated, patented products (40% of branded portfolio) to drive better margins.
→Introduction of biostimulant (bio-product) portfolio with 5 new products targeted at growth enhancement and yield improvement.
→Emphasis on operational efficiency, working capital optimization, and inventory reduction to support sustainable growth.
→No specific revenue guidance given, but management confident of stronger, more stable growth and better financial performance ahead.

📈 Profitability & Margins

→FY26 was challenging with reduced revenue and profits; FY27 expected to improve but no specific guidance provided.
→Management expects FY27 to deliver better top line and bottom line due to calibrated price increases and increased B2B technical sales.
→Introduction of new patented products and biostimulants expected to support growth.
→B2B segment expansion with new off-patent molecules production starting Q1 FY27 aims to provide steady revenue with fixed payment cycles.
→Gross margin improvement recorded in FY26 (30% from 29%), expected to continue with better product mix and pricing.
→Operating expenses have been reduced (~15% reduction in OPEX), improving operational efficiency.
→Sales deferred in Q4 FY26 due to price hikes are expected to contribute to better revenues in Q1 FY27.
→EBITDA margin for branded expected around 18-20% and B2B around 8%, projecting improved profitability.
→Despite no concrete EPS guidance, management confident of a stronger, sustainable financial performance going forward.

See what Best Agrolife Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→The company has postponed new capex planned for the existing plant as of FY26 and is putting it on hold (Page 7).
→Existing manufacturing capacity is currently sufficient and well-utilized (80-90% in season, 50-60% off-season) (Page 8).
→Setting up a similar manufacturing facility from scratch would require approximately ₹80-100 crore (Page 8).
→R&D spend will continue around 1% of sales, focusing on patented products and new patents (expecting 2-3 new patents in 2026-27) (Page 7).
→No immediate new large-scale capital investment is underway; focus remains on operational efficiency and working capital optimization (Page 5-7).

💰 Fundraising & Capital Structure

→The company has not indicated any immediate plans for a new rights issue or equity fundraising.
→Management acknowledges the need for strong capitalization but is currently managing liquidity through existing bank facilities and government schemes.
→Bank facilities utilization is around 85-90%, with about 10% still available for use.
→The company has applied for additional funding support from the central government (20% additional funding) to meet seasonal capital requirements.
→No specific mention of new debt raising but existing borrowings are being managed efficiently.
→Capex plans are postponed to conserve capital and focus on working capital and R&D.
→Overall, the management seems focused on internal cash flow and bank credit rather than new equity fundraising for now.

See what Best Agrolife Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

→No explicit mention of a current or expected order book or pending orders volume is found in the transcript.
→However, discussion indicates sales deferral of Rs. 50-70 crore from March to Q1 FY27 due to price revision expectations.
→Orders are expected to improve in Q1 FY27 with increased prices and better placements.
→The company is diversifying B2B segment with production of four new off-patent molecules starting Q1 FY27.
→Pricing actions and inventory management are expected to support gradual recovery and better cash flow going forward.
→Management indicated cautious manufacturing and procurement planning aligned with demand.
→Overall, company anticipates a stronger top line and profitability in the upcoming quarters supported by these strategic actions.

Key Metrics

How does Best Agrolife Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Best Agrolife Ltd

See full Fertilizers & Agrochemicals sector rankings

What BESTAGRO's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

IGCL (Q4 FY26)
Successful single order in Venezuela contributing approximately INR 4 crores in revenue, indicating active export orders. Key concall takeaways from Indogulf…
Rallis India Ltd (Q4 FY26)
Crop Protection B2C business growth excluding Soil & Plant Health (SPH) will be marginally positive to low single digit; SPH segment grew robustly at 27%. Key…
PUNJABCHEM (Q4 FY26)
Overall volume growth in FY '26 was around 14%, primarily driven by new products. Key concall takeaways from Punjab Chemicals & Crop Protection Ltd's Q4 FY26…
Krishana Phoschem Ltd (Q4 FY26)
The Company has recently completed a significant capacity expansion: NPK/DAP capacity increased by 50% to 495,000 MTPA, SSP capacity at 120,000 MTPA, totaling…

Compare:vs Coromandel International Ltd vs FACT vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Best Agrolife Ltd Q4 FY26 results?

What is Best Agrolife Ltd share price analysis?

Best Agrolife Ltd currently shows a neutral. The stock trades at a P/E of 25.1 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is Best Agrolife Ltd planning capital expenditure?

The company has postponed new capex planned for the existing plant as of FY26 and is putting it on hold (Page 7).

Keep Best Agrolife Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.